Search
Belite Bio Inc
BLTEAdd to Watchlist
147.330USD
-2.940-1.96%
Close 10-23 16:00（ET）
5.53BMarket Cap
LossP/E TTM
Belite Bio Inc (BLTE) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Belite Bio Inc in the past month.
Buy
2 Strong Buy
7 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
228.889USD+60.31%
BLTE Analyst Recommendation Trends
In the current month, BLTE has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BLTE average Analyst price target in the last month is 228.889.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
2
2
2
2
2
2
7
7
6
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
8
8
8
8
8
8
Financial Forecasting
Based on analysts' estimates, BLTE EPS is projected to reach -0.768 in FY2026Q3, following reported EPS of -0.707 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.55
-0.64
-0.79
-0.77
-0.90
Actual
-1.19
-0.68
-0.71
--
--
Surprise
-117.22%
-6.29%
+10.35%
--
--
FAQs
What is Belite Bio Inc's price target?
Analysts forecast that Belite Bio Inc's price target is USD 91.50, with the highest forecast at USD 110.00 and the lowest forecast at USD 80.00.
How have Belite Bio IncBLTE's recent earnings per share performed?
The market expectation was USD -0.71, while Belite Bio IncBLTE's earnings per share (EPS) for the previous quarter was USD -0.68. EPS for the next quarter is expected at USD -0.77.
What is the analyst rating for Belite Bio Inc?
Based on the ratings of Belite Bio Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.